BioCentury
ARTICLE | Clinical News

Viaskin Milk: Completed Ph I/II enrollment

November 9, 2016 10:00 PM UTC

DBV completed enrollment of about 176 patients ages 2-17 in the Phase II portion of the double-blind, placebo-controlled, North American Phase I/II MILES trial evaluating 150, 300 and 500 μg Viaskin M...

BCIQ Company Profiles

DBV Technologies S.A.